COVID-19 trials registries data warehouse

 Return to trial list

Trial - RBR-4kjqtg


Column Value
Trial registration number RBR-4kjqtg
Full text link
Last imported at : Jan. 8, 2021, 12:45 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

First author
Last imported at : Dec. 15, 2020, 2:47 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Ana Paula;André Kipnis;Kipnis

Contact
Last imported at : Dec. 15, 2020, 2:47 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

ana_kipnis@ufg.br; akipnis@ufg.br

Registration date
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2020-08-05

Recruitment status
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not recruiting

Study design
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

RCT

Allocation
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Randomized

Design
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Parallel

Masking
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Open label

Center
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

unclear

Study aim
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Prevention

Inclusion criteria
Last imported at : Nov. 6, 2020, 11:45 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

HW with BCG scar, adults, over 18 years old,who have negative IgM and IgG COVID-19 test, regardless of gender, dedicating at least 8 hours a week to care for individuals suspected of having COVID-19.

Exclusion criteria
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Participants with any of the following characteristics will be excluded: Individuals who have had a fever in the last 15 days, pregnant or lactating women, individuals with suspected viral infection including COVID-19 or bacterial in the past 15 days before randomization, have had a previous diagnosis of tuberculosis, has had a vaccination in the last 15 days, immunocompromised or with neutrophil count below 500 / mm3, using corticosteroids, antibiotics and chemotherapy drugs, present or have presented a solid or non-solid tumor in the last 2 years, or who are directly involved in the project.

Number of arms
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2

Funding
Last imported at : Dec. 15, 2020, 2:47 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Universidade Federal de Goias

Inclusion age min
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

18

Inclusion age max
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

100

Countries
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Brazil

Type of patients
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Health workers

Severity scale
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

N/A

Total sample size
Last imported at : Dec. 15, 2020, 2:47 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

0

primary outcome
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Reduction of health problems of health care workers related to COVID-19 among individuals vaccinated with BCG; verified by clinical evaluation and laboratory exames during 180 days.;Reduction of positivity for COVID-19 through serological; molecular tests and / or clinical evaluation among individuals vaccinated with BCG.

Notes
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Phase
Last imported at : Nov. 6, 2020, 11:45 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Phase 2

Arms
Last imported at : Dec. 10, 2021, 2 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

[{"arm_notes": "1", "treatment_id": 186, "treatment_name": "Bcg vaccine", "treatment_type": "Non covid vaccine", "pharmacological_treatment": "Non covid vaccine"}, {"arm_notes": "1", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]